Developing Vaccines at Pandemic Speed

Time: 8:30 am
day: Day Two


  • Highlighting approaches in vaccine development to be prepared for future potential pandemic infectious diseases and share our historical experiences with Ebola and Coronavirus
  • How Merck responded to the Ebola outbreak, share our experience partnering with other companies, government, health, and regulatory agencies, and non-government organizations to develop and implement a vaccine to address the outbreak
  • How Merck’s development efforts for our COVID-19 program were significantly accelerated by using the previously-developed Ebola platform
  • Lessons learned and future preparations to respond to the next global infectious disease